NRX-1074 in Early Course Schizophrenia

NCT02603458 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was withdrawn by the sponsor.

Conditions

Schizophrenia

Interventions

DRUG: NRX-1074
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]